Scarica l'app Stockscreener
1.63
6.86%
-0.12
Dopo l'orario di chiusura:
1.67
0.04
+2.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NMRA Giù?
Forum
Previsione
Precedente Chiudi:
$1.75
Aprire:
$1.74
Volume 24 ore:
484.00K
Relative Volume:
0.36
Capitalizzazione di mercato:
$263.97M
Reddito:
-
Utile/perdita netta:
$-274.18M
Rapporto P/E:
-0.6431
EPS:
-2.5346
Flusso di cassa netto:
$-198.33M
1 W Prestazione:
-7.39%
1M Prestazione:
-1.21%
6M Prestazione:
+15.60%
1 anno Prestazione:
-85.17%
Intervallo 1D:
$1.615
$1.765
Intervallo di 1 settimana:
$1.615
$1.835
Portata 52W:
$0.611
$17.19
Neumora Therapeutics Inc Stock (NMRA) Company Profile
Nome
Neumora Therapeutics Inc
Settore
Industria
Telefono
(857) 760-0900
Indirizzo
260 ARSENAL PLACE, SUITE 1, WATERTOWN
Confronta NMRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NMRA
Neumora Therapeutics Inc
|
1.63 | 281.79M | 0 | -274.18M | -198.33M | -2.5346 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Neumora Therapeutics Inc Stock (NMRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-03-10 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-03-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2025-03-07 | Downgrade | Stifel | Buy → Hold |
| 2025-01-02 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-11-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-10-01 | Iniziato | H.C. Wainwright | Buy |
| 2024-07-22 | Iniziato | Needham | Buy |
| 2024-07-08 | Iniziato | Mizuho | Outperform |
| 2023-12-12 | Iniziato | Deutsche Bank | Hold |
| 2023-10-10 | Iniziato | BofA Securities | Buy |
| 2023-10-10 | Iniziato | Guggenheim | Buy |
| 2023-10-10 | Iniziato | JP Morgan | Overweight |
| 2023-10-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-10-10 | Iniziato | Stifel | Buy |
| 2023-10-10 | Iniziato | William Blair | Outperform |
Mostra tutto
Neumora Therapeutics Inc Borsa (NMRA) Ultime notizie
Can Neumora Therapeutics Inc. sustain its profitabilityTrade Exit Summary & Daily Chart Pattern Signals - khodrobank.com
Has Neumora Therapeutics Inc. formed a bullish divergenceTrade Entry Report & High Accuracy Trade Alerts - Newser
Why Neumora Therapeutics Inc. is moving todayJuly 2025 Short Interest & AI Based Buy and Sell Signals - Newser
What machine learning models say about Neumora Therapeutics Inc.Portfolio Performance Summary & Fast Entry High Yield Tips - Newser
Can trapped investors hope for a rebound in Neumora Therapeutics Inc2025 Dividend Review & Fast Gaining Stock Strategy Reports - Newser
Custom watchlist performance reports with Neumora Therapeutics Inc.Quarterly Profit Review & Long-Term Capital Growth Strategies - Newser
Using RSI to spot recovery in Neumora Therapeutics Inc.Portfolio Risk Summary & Reliable Entry Point Trade Alerts - Newser
Will Neumora Therapeutics Inc. benefit from sector rotationPortfolio Growth Summary & Risk Adjusted Swing Trade Ideas - khodrobank.com
Applying big data sentiment scoring on Neumora Therapeutics Inc.Dip Buying & Advanced Swing Trade Entry Alerts - Newser
Can trapped investors hope for a rebound in Neumora Therapeutics Inc.Weekly Profit Summary & Fast Exit and Entry Strategy Plans - Newser
Published on: 2025-09-03 02:32:48 - Newser
Can swing trading help recover from Neumora Therapeutics Inc. lossesJuly 2025 Analyst Calls & Low Risk High Reward Ideas - Newser
How to forecast Neumora Therapeutics Inc. trends using time series2025 Biggest Moves & Community Consensus Picks - Newser
Is now the right time to enter Neumora Therapeutics Inc.July 2025 Action & Long Hold Capital Preservation Tips - khodrobank.com
Can Neumora Therapeutics Inc. stock double in the next year2025 Volatility Report & Low Risk Profit Maximizing Plans - khodrobank.com
Can momentum traders help lift Neumora Therapeutics Inc.Weekly Gains Report & Weekly Setup with High ROI Potential - Newser
Neumora Therapeutics Inc. stock prediction for this weekJuly 2025 Rallies & Target Return Focused Stock Picks - Newser
Published on: 2025-09-03 06:19:09 - khodrobank.com
Can Neumora Therapeutics Inc. navigate macro headwindsQuarterly Profit Review & Free High Accuracy Swing Entry Alerts - khodrobank.com
Is Neumora Therapeutics Inc. a candidate for recovery playJuly 2025 Breakouts & Weekly Watchlist of Top Performers - Newser
Will Neumora Therapeutics Inc. benefit from geopolitical trendsSwing Trade & Low Risk Entry Point Guides - khodrobank.com
Will a bounce in Neumora Therapeutics Inc. offer an exit2025 Trading Recap & Daily Stock Trend Reports - Newser
Reversal indicators forming on Neumora Therapeutics Inc. stock2025 Key Lessons & Free Real-Time Market Sentiment Alerts - Newser
What are Neumora Therapeutics Inc.’s earnings expectations2025 Sector Review & Smart Money Movement Tracker - khodrobank.com
Is Neumora Therapeutics Inc. stock heavily shortedJuly 2025 Opening Moves & Weekly Breakout Watchlists - khodrobank.com
How liquid is Neumora Therapeutics Inc. stock2025 Fundamental Recap & Growth Focused Stock Reports - khodrobank.com
Published on: 2025-09-02 06:45:35 - Newser
How to monitor Neumora Therapeutics Inc. with trend dashboardsEarnings Risk Report & Weekly Top Stock Performers List - Newser
Neumora Therapeutics to Participate in Upcoming Conferences in September - MarketScreener
Clinical-Stage Biotech Neumora Therapeutics to Present at Wells Fargo, Morgan Stanley Healthcare Events - Stock Titan
Technical analysis overview for Neumora Therapeutics Inc. stockVolume Spike & Advanced Technical Signal Analysis - Newser
Is Neumora Therapeutics Inc. part of any ETFMarket Activity Report & Community Verified Watchlist Alerts - khodrobank.com
Big Money Moves: Can Neumora Therapeutics Inc. sustain its profitabilityMarket Movement Recap & AI Enhanced Execution Alerts - khodrobank.com
What are the future prospects of Neumora Therapeutics Inc.Portfolio Gains Report & Risk Controlled Stock Alerts - khodrobank.com
Short interest data insights for Neumora Therapeutics Inc.Dividend Hike & Precise Entry and Exit Recommendations - Newser
Published on: 2025-09-01 15:26:23 - beatles.ru
Key metrics from Neumora Therapeutics Inc.’s quarterly dataMarket Sentiment Review & Weekly Consistent Profit Watchlists - Newser
Is Neumora Therapeutics Inc. subject to activist investor interestProfit Target & Capital Efficient Trade Techniques - khodrobank.com
Can Neumora Therapeutics Inc. recover in the next quarter2025 Biggest Moves & Real-Time Sentiment Analysis - Newser
Applying big data sentiment scoring on Neumora Therapeutics IncGap Up & High Accuracy Investment Signals - Newser
Traders Watching For Reversal Pattern in Neumora Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Applying chart zones and confluence areas to Neumora Therapeutics Inc.July 2025 Catalysts & Community Verified Swing Trade Signals - Newser
Neumora Therapeutics Inc Azioni (NMRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Neumora Therapeutics Inc Azioni (NMRA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BERNS PAUL L | See Remarks |
Feb 18 '25 |
Sale |
1.69 |
13,871 |
23,468 |
7,405,004 |
| Milligan Michael Lee | See Remarks |
Feb 18 '25 |
Sale |
1.69 |
1,978 |
3,351 |
22,470 |
| Aurora Daljit Singh | Chief Strategy Officer |
Feb 18 '25 |
Sale |
1.68 |
8,565 |
14,347 |
88,935 |
| Lenz Robert A. | Head of R&D |
Feb 18 '25 |
Sale |
1.67 |
5,614 |
9,383 |
309,092 |
| Pinto Joshua | President |
Feb 18 '25 |
Sale |
1.67 |
8,048 |
13,477 |
76,952 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):